Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1189-2008

Bio-Rad MONOLISA Anti-HBc EIA, Catalog Number 26186. In vitro diagnostic

Bio-Rad Laboratories Inc. / initiated 2008-01-07 / Terminated / root cause: manufacturing process

Bio-Rad Laboratories began a recall of Bio-Rad MONOLISA Anti-HBc EIA, Catalog Number 26186. In vitro diagnostic on . The reason FDA records is "Incorrect result: Elevated reactivity with a kit lot 232BGG. Patient samples that are negative for antibodies to anti-HBc could be assigned a positive result". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1189-2008
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Bio-Rad Laboratories Inc.
Product
Bio-Rad MONOLISA Anti-HBc EIA, Catalog Number 26186. In vitro diagnostic.
Reason for recall
Incorrect result: Elevated reactivity with a kit lot 232BGG. Patient samples that are negative for antibodies to anti-HBc could be assigned a positive result.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Bio-Rad called each customer and alerted them to the issue on 1/7-8/2008. A letter was faxed and sent via overnight carrier (DHL) to each customer site on 1/8/2008. Customers were told not to use the affected lot of the product and to discard it. The firm will provide another lot of the product to customers.
Quantity in commerce
31 distributed
Distribution
Nationwide Distribution.
Product codes and lots
Lot Number 232BGG